ATRIAL FIBRILLATION, WEARABLE TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE: CURRENT EVIDENCE, CLINICAL UTILITY AND LIMITATIONS
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.5766Keywords:
Atrial Fibrillation, Wearable Devices, Smartwatch, Artificial Intelligence, Photoplethysmography, Electrocardiography, ScreeningAbstract
Background: Atrial fibrillation is the most common sustained cardiac arrhythmia in adults and represents an important clinical and public health problem because of its association with stroke, mortality, disability, and healthcare burden. Its paroxysmal and frequently asymptomatic course limits the effectiveness of conventional diagnostic strategies based on occasional electrocardiographic recordings.
Aim: This narrative review aims to summarise current evidence regarding the use of wearable technologies and artificial intelligence for the detection of atrial fibrillation, with particular emphasis on diagnostic accuracy, clinical utility, and principal limitations.
Methods: A structured literature search was performed using PubMed, Scopus, Web of Science, and Google Scholar. Studies published between 2021 and 2026 were primarily considered. Search terms included “atrial fibrillation,” “wearable technologies,” “smartwatch,” “electrocardiography,” “photoplethysmography,” “artificial intelligence,” “machine learning,” and “diagnostics.” Priority was given to original studies, systematic reviews, meta-analyses, and clinically relevant review articles concerning wearable devices, artificial intelligence, and atrial fibrillation detection. Earlier landmark studies were included when they were necessary to explain key evidence discussed in recent reviews and meta-analyses.
Results: Wearable devices such as smartwatches, fitness bands, and portable ECG systems allow longer heart rhythm monitoring in daily life and may help detect paroxysmal and clinically silent atrial fibrillation. ECG-based devices are more consistent with current diagnostic standards, whereas photoplethysmography-based systems are more accessible and can provide passive rhythm monitoring. Artificial intelligence, especially machine learning and deep learning, can support signal interpretation, arrhythmia recognition, and risk prediction. However, diagnostic performance reported in controlled studies may not always translate directly into real-world clinical practice.
Conclusions: Wearable technologies and artificial intelligence offer a promising way to support atrial fibrillation screening and monitoring. They may improve early detection, especially in asymptomatic individuals, but should not replace standard diagnostic methods. Photoplethysmography-based alerts should be regarded as screening signals, while a final diagnosis of atrial fibrillation should still be confirmed by ECG in an appropriate clinical context. More large-scale studies are needed before these tools can be widely implemented in routine practice.
References
Sagris, M., Vardas, E. P., Theofilis, P., Antonopoulos, A. S., Oikonomou, E., & Tousoulis, D. (2022). Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int J Mol Sci, 23(1), 6. https://doi.org/10.3390/ijms23010006
Choi, S. E., Sagris, D., Hill, A., Lip, G. Y. H., & Abdul-Rahim, A. H. (2023). Atrial fibrillation and stroke. Expert Rev Cardiovasc Ther, 21(1), 35-56. https://doi.org/10.1080/14779072.2023.2160319
Kashou, A. H., Adedinsewo, D. A., & Noseworthy, P. A. (2022). Subclinical Atrial Fibrillation: A Silent Threat with Uncertain Implications. Annu Rev Med, 73, 355-362. https://doi.org/10.1146/annurev-med-042420-105906
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., et al. (2021). 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 42(5), 373-498. https://doi.org/10.1093/eurheartj/ehaa612
Chan, N. Y., Cheng, W. H., & Chao, T. F. (2025). How to screen for atrial fibrillation on a community level: Recent advances. Kardiol Pol, 83(9), 997-1004. https://doi.org/10.33963/v.phj.107879
Bonini, N., Vitolo, M., Imberti, J. F., Proietti, M., Romiti, G. F., Boriani, G., et al. (2022). Mobile health technology in atrial fibrillation. Expert Rev Med Devices, 19(4), 327-340. https://doi.org/10.1080/17434440.2022.2070005
Wang, Y. C., Xu, X., Hajra, A., Apple, S., Kharawala, A., Duarte, G., et al. (2022). Current Advancement in Diagnosing Atrial Fibrillation by Utilizing Wearable Devices and Artificial Intelligence: A Review Study. Diagnostics (Basel), 12(3), 689. https://doi.org/10.3390/diagnostics12030689
Karakasis, P., Theofilis, P., Sagris, M., Pamporis, K., Stachteas, P., Sidiropoulos, G., et al. (2025). Artificial Intelligence in Atrial Fibrillation: From Early Detection to Precision Therapy. J Clin Med, 14(8), 2627. https://doi.org/10.3390/jcm14082627
Ding, C., Xiao, R., Wang, W., Holdsworth, E., & Hu, X. (2024). Photoplethysmography based atrial fibrillation detection: a continually growing field. Physiol Meas, 45(4), 04TR01. https://doi.org/10.1088/1361-6579/ad37ee
Lawin, D., Kuhn, S., Schulze Lammers, S., Lawrenz, T., & Stellbrink, C. (2022). Use of digital health applications for the detection of atrial fibrillation. Herzschrittmacherther Elektrophysiol, 33(4), 373-379. https://doi.org/10.1007/s00399-022-00888-2
Nasser, A., Michalczak, M., Żądło, A., & Tokarek, T. (2025). AI-Powered Precision: Revolutionizing Atrial Fibrillation Detection with Electrocardiograms. J Clin Med, 14(14), 4924. https://doi.org/10.3390/jcm14144924
Chatterjee, K., Verma, A., Godinez, E., Gonzalez, D. J., Devathu, R., Alhusseini, M. I., et al. (2026). Artificial intelligence in atrial fibrillation — Timely diagnosis, risk assessment and personalized management. Indian Pacing Electrophysiol J https://doi.org/10.1016/j.ipej.2026.01.011
Prasitlumkum, N., Cheungpasitporn, W., Chokesuwattanaskul, A., Thangjui, S., Thongprayoon, C., Bathini, T., et al. (2021). Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: A systematic review and meta-analysis. Arch Cardiovasc Dis, 114(1), 4-16. https://doi.org/10.1016/j.acvd.2020.05.015
Barrera, N., Solorzano, M., Jimenez, Y., Kushnir, Y., Gallegos-Koyner, F., & Dagostin de Carvalho, G. (2025). Accuracy of Smartwatches in the Detection of Atrial Fibrillation: A Systematic Review and Diagnostic Meta-Analysis. JACC Adv, 4(11 Pt 1), 102133. https://doi.org/10.1016/j.jacadv.2025.102133
Țica, O., Champsi, A., Duan, J., & Țica, O. (2025). Artificial Intelligence in the Diagnosis and Management of Atrial Fibrillation. Diagnostics (Basel), 15(20), 2561. https://doi.org/10.3390/diagnostics15202561
Antoun, I., Abdelrazik, A., Eldesouky, M., Li, X., Layton, G. R., Zakkar, M., et al. (2025). Artificial intelligence in atrial fibrillation: emerging applications, research directions and ethical considerations. Front Cardiovasc Med, 12, 1596574. https://doi.org/10.3389/fcvm.2025.1596574
Islam, S., Islam, M. R., Sanjid-E-Elahi, Abedin, M. A., Dökeroğlu, T., & Rahman, M. (2025). Recent advances in the tools and techniques for AI-aided diagnosis of atrial fibrillation. Biophys Rev (Melville), 6(1), 011301. https://doi.org/10.1063/5.0217416
Perez, M. V., Mahaffey, K. W., Hedlin, H., Rumsfeld, J. S., Garcia, A., Ferris, T., et al. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. N Engl J Med, 381(20), 1909-1917. https://doi.org/10.1056/NEJMoa1901183
Lubitz, S. A., Faranesh, A. Z., Selvaggi, C., Atlas, S. J., McManus, D. D., Singer, D. E., et al. (2022). Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study. Circulation, 146(19), 1415-1424. https://doi.org/10.1161/CIRCULATIONAHA.122.060291
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Radosław Kołodziej, Kacper Szpanelewski, Jakub Klecha, Joanna Ciemięga, Anna Kołodziej, Szczepan Półchłopek, Szymon Lulek, Izabella Kula, Emilia Kucab, Damian Danilczuk, Katarzyna Dziki, Wiktor Adamiec
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
